Shusei Hamamichi, Ph.D. - Publications

Affiliations: 
2009 Biological Sciences The University of Alabama, Tuscaloosa, AL 

15/33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Gaeta AL, Nourse JB, Willicott K, McKay LE, Keogh CM, Peter K, Russell SN, Hamamichi S, Berkowitz LA, Caldwell KA, Caldwell GA. Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans. Plos Genetics. 18: e1010115. PMID 35984862 DOI: 10.1371/journal.pgen.1010115  0.563
2014 Knight AL, Yan X, Hamamichi S, Ajjuri RR, Mazzulli JR, Zhang MW, Daigle JG, Zhang S, Borom AR, Roberts LR, Lee SK, DeLeon SM, Viollet-Djelassi C, Krainc D, O'Donnell JM, et al. The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models. Cell Metabolism. 20: 145-57. PMID 24882066 DOI: 10.1016/J.Cmet.2014.04.017  0.586
2014 Matlack KE, Tardiff DF, Narayan P, Hamamichi S, Caldwell KA, Caldwell GA, Lindquist S. Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity. Proceedings of the National Academy of Sciences of the United States of America. 111: 4013-8. PMID 24591589 DOI: 10.1073/Pnas.1402228111  0.566
2014 Muñoz-Lobato F, Rodríguez-Palero MJ, Naranjo-Galindo FJ, Shephard F, Gaffney CJ, Szewczyk NJ, Hamamichi S, Caldwell KA, Caldwell GA, Link CD, Miranda-Vizuete A. Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. Antioxidants & Redox Signaling. 20: 217-35. PMID 23641861 DOI: 10.1089/Ars.2012.5051  0.605
2011 Treusch S, Hamamichi S, Goodman JL, Matlack KE, Chung CY, Baru V, Shulman JM, Parrado A, Bevis BJ, Valastyan JS, Han H, Lindhagen-Persson M, Reiman EM, Evans DA, Bennett DA, et al. Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science (New York, N.Y.). 334: 1241-5. PMID 22033521 DOI: 10.1126/Science.1213210  0.56
2011 Liu Z, Hamamichi S, Lee BD, Yang D, Ray A, Caldwell GA, Caldwell KA, Dawson TM, Smith WW, Dawson VL. Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models. Human Molecular Genetics. 20: 3933-42. PMID 21768216 DOI: 10.1093/Hmg/Ddr312  0.673
2010 Yacoubian TA, Slone SR, Harrington AJ, Hamamichi S, Schieltz JM, Caldwell KA, Caldwell GA, Standaert DG. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death & Disease. 1: e2. PMID 21152247 DOI: 10.1038/Cddis.2009.4  0.75
2010 Harrington AJ, Hamamichi S, Caldwell GA, Caldwell KA. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 239: 1282-95. PMID 20108318 DOI: 10.1002/Dvdy.22231  0.74
2010 Su LJ, Auluck PK, Outeiro TF, Yeger-Lotem E, Kritzer JA, Tardiff DF, Strathearn KE, Liu F, Cao S, Hamamichi S, Hill KJ, Caldwell KA, Bell GW, Fraenkel E, Cooper AA, et al. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Disease Models & Mechanisms. 3: 194-208. PMID 20038714 DOI: 10.1242/Dmm.004267  0.74
2009 Kritzer JA, Hamamichi S, McCaffery JM, Santagata S, Naumann TA, Caldwell KA, Caldwell GA, Lindquist S. Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models. Nature Chemical Biology. 5: 655-63. PMID 19597508 DOI: 10.1038/Nchembio.193  0.627
2009 Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, Caldwell KA, Caldwell GA, Cooper AA, Rochet JC, Lindquist S. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nature Genetics. 41: 308-15. PMID 19182805 DOI: 10.1038/Ng.300  0.733
2008 Berkowitz LA, Hamamichi S, Knight AL, Harrington AJ, Caldwell GA, Caldwell KA. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes. Journal of Visualized Experiments : Jove. PMID 19066512 DOI: 10.3791/835  0.747
2008 Qiao L, Hamamichi S, Caldwell KA, Caldwell GA, Yacoubian TA, Wilson S, Xie ZL, Speake LD, Parks R, Crabtree D, Liang Q, Crimmins S, Schneider L, Uchiyama Y, Iwatsubo T, et al. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Molecular Brain. 1: 17. PMID 19021916 DOI: 10.1186/1756-6606-1-17  0.601
2008 Hamamichi S, Rivas RN, Knight AL, Cao S, Caldwell KA, Caldwell GA. Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proceedings of the National Academy of Sciences of the United States of America. 105: 728-33. PMID 18182484 DOI: 10.1073/Pnas.0711018105  0.772
2008 Gitler AD, Bevis BJ, Shorter J, Strathearn KE, Hamamichi S, Su LJ, Caldwell KA, Caldwell GA, Rochet JC, McCaffery JM, Barlowe C, Lindquist S. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 105: 145-50. PMID 18162536 DOI: 10.1073/Pnas.0710685105  0.677
Low-probability matches (unlikely to be authored by this person)
2022 Yamazaki K, Matsuo K, Okada A, Uno N, Suzuki T, Abe S, Hamamichi S, Kishima N, Togai S, Tomizuka K, Kazuki Y. Simultaneous loading of PCR-based multiple fragments on mouse artificial chromosome vectors in DT40 cell for gene delivery. Scientific Reports. 12: 21790. PMID 36526651 DOI: 10.1038/s41598-022-25959-9  0.192
2023 Togai S, Hamamichi S, Kazuki Y, Hiratsuka M. Pathological Comparison of TDP-43 Between Motor Neurons and Interneurons Expressed by a Tetracycline Repressor System on the Mouse Artificial Chromosome. Yonago Acta Medica. 66: 24-35. PMID 36820298 DOI: 10.33160/yam.2023.02.004  0.185
2020 Hamamichi S, Fukuhara T, Hattori N. Immunotoxin Screening System: A Rapid and Direct Approach to Obtain Functional Antibodies with Internalization Capacities. Toxins. 12. PMID 33076544 DOI: 10.3390/toxins12100658  0.107
2021 Abe S, Honma K, Okada A, Kazuki K, Tanaka H, Endo T, Morimoto K, Moriwaki T, Hamamichi S, Nakayama Y, Suzuki T, Takehara S, Oshimura M, Kazuki Y. Construction of stable mouse artificial chromosome from native mouse chromosome 10 for generation of transchromosomic mice. Scientific Reports. 11: 20050. PMID 34625612 DOI: 10.1038/s41598-021-99535-y  0.096
2023 Yamazaki K, Matsuo K, Okada A, Uno N, Suzuki T, Abe S, Hamamichi S, Kishima N, Togai S, Tomizuka K, Kazuki Y. Publisher Correction: Simultaneous loading of PCR-based multiple fragments on mouse artificial chromosome vectors in DT40 cell for gene delivery. Scientific Reports. 13: 3406. PMID 36854786 DOI: 10.1038/s41598-023-30359-8  0.091
2023 Satofuka H, Wang Y, Yamazaki K, Hamamichi S, Fukuhara T, Rafique A, Osako N, Kanazawa I, Endo T, Miyake N, Honma K, Nagashima Y, Hichiwa G, Shimoya K, Abe S, et al. Characterization of human anti-EpCAM antibodies for developing an antibody-drug conjugate. Scientific Reports. 13: 4225. PMID 36918661 DOI: 10.1038/s41598-023-31263-x  0.087
2024 Miyamoto H, Kobayashi H, Kishima N, Yamazaki K, Hamamichi S, Uno N, Abe S, Hiramuki Y, Kazuki K, Tomizuka K, Kazuki Y. Rapid human genomic DNA cloning into mouse artificial chromosome via direct chromosome transfer from human iPSC and CRISPR/Cas9-mediated translocation. Nucleic Acids Research. PMID 38180813 DOI: 10.1093/nar/gkad1218  0.081
2023 Uno N, Satofuka H, Miyamoto H, Honma K, Suzuki T, Yamazaki K, Ito R, Moriwaki T, Hamamichi S, Tomizuka K, Oshimura M, Kazuki Y. Treatment of CHO cells with Taxol and reversine improves micronucleation and microcell-mediated chromosome transfer efficiency. Molecular Therapy. Nucleic Acids. 33: 391-403. PMID 37547291 DOI: 10.1016/j.omtn.2023.07.002  0.078
2015 Ito K, Hamamichi S, Asano M, Hori Y, Matsui J, Iwata M, Funahashi Y, Umeda IO, Fujii H. Radiolabeled Liposome Imaging Determines an Indication for Liposomal Anti-cancer Agent in Ovarian Cancer Mouse Xenograft Models. Cancer Science. PMID 26509883 DOI: 10.1111/cas.12841  0.077
2017 Ito K, Hamamichi S, Abe T, Akagi T, Shirota H, Kawano S, Asano M, Asano O, Yokoi A, Matsui J, Umeda IO, Fujii H. Anti-tumor Effects of Eribulin Depend on the Modulation of Tumor Microenvironment by Vascular Remodeling in Mouse Models. Cancer Science. PMID 28869796 DOI: 10.1111/cas.13392  0.067
2023 Umeda IO, Koike Y, Ogata M, Kaneko E, Hamamichi S, Uehara T, Moribe K, Arano Y, Takahashi T, Fujii H. New liposome-radionuclide-chelate combination for tumor targeting and rapid healthy tissue clearance. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 37543291 DOI: 10.1016/j.jconrel.2023.07.060  0.054
2021 Hamamichi S, Fukuhara T, Umeda IO, Fujii H, Hattori N. Novel method for screening functional antibody with comprehensive analysis of its immunoliposome. Scientific Reports. 11: 4625. PMID 33633189 DOI: 10.1038/s41598-021-84043-w  0.052
2001 Hamamichi S, Nishigori H. Establishment of a chick embryo shell-less culture system and its use to observe change in behavior caused by nicotine and substances from cigarette smoke. Toxicology Letters. 119: 95-102. PMID 11311570 DOI: 10.1016/S0378-4274(00)00300-3  0.049
2015 Fujii H, Iimoto T, Tsuzuki T, Iiizumi S, Someya S, Hamamichi S, Kessler MM. COLLABORATION OF LOCAL GOVERNMENTS AND EXPERTS RESPONDING TO THE INCREASE OF THE ENVIRONMENTAL RADIATION LEVEL SECONDARY TO THE NUCLEAR ACCIDENT: A UNIQUE ACTIVITY TO RELIEVE RESIDENTS' ANXIETY. Radiation Protection Dosimetry. PMID 25953792 DOI: 10.1093/rpd/ncv281  0.048
2017 Hori Y, Ito K, Hamamichi S, Ozawa Y, Matsui J, Umeda IO, Fujii H. Functional Characterization of VEGF- and FGF-induced Tumor Blood Vessel Models in Human Cancer Xenografts. Anticancer Research. 37: 6629-6638. PMID 29187438 DOI: 10.21873/anticanres.12120  0.047
2003 Hamamichi S, Kosano H, Nakai S, Ogihara-Umeda I, Nishigori H. Involvement of hepatic glucocorticoid receptor-mediated functions in steroid-induced cataract formation. Experimental Eye Research. 77: 575-80. PMID 14550399 DOI: 10.1016/S0014-4835(03)00193-3  0.047
2016 Ito K, Hamamichi S, Asano M, Hori Y, Matsui J, Iwata M, Funahashi Y, Umeda IO, Fujii H. (111) In-encapsulated liposome-distribution in mouse xenografts of human ovarian cancer. Cancer Science. 107: 1. PMID 26805934 DOI: 10.1111/cas.12775  0.042
2014 Nakagami R, Yamaguchi M, Ezawa K, Kimura S, Hamamichi S, Sekine N, Furukawa A, Niitsu M, Fujii H. Recovery correction technique for NMR spectroscopy of perchloric acid extracts using DL-valine-2,3-d2: validation and application to 5-fluorouracil-induced brain damage. Magnetic Resonance in Medical Sciences : Mrms : An Official Journal of Japan Society of Magnetic Resonance in Medicine. 13: 145-53. PMID 24990468 DOI: DN/JST.JSTAGE/mrms/2013-0089  0.04
Hide low-probability matches.